JANICE BLALOCK

TitleAssociate Professor
InstitutionMD Anderson
DepartmentBehavioral Science
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kypriotakis G, Kim S, Karam-Hage M, Robinson JD, Minnix JA, Blalock JA, Cui Y, Beneventi D, Kim B, Pan IW, Shih YT, Cinciripini PM. Examining the Association between Abstinence from Smoking and Healthcare Costs Among Patients with Cancer. Cancer Prev Res (Phila). 2023 Nov 08. PMID: 37940143.
      Citations:    Fields:    
    2. Robinson JD, Kypriotakis G, Karam-Hage M, Cui Y, Beneventi D, Blalock JA, Minnix JA, Cinciripini PM. Brief report: Characterization of electronic cigarette use among patients of a comprehensive cancer center. Am J Addict. 2023 Oct 08. PMID: 37807121.
      Citations:    Fields:    
    3. Cinciripini PM, Minnix JA, Robinson JD, Kypriotakis G, Cui Y, Blalock JA, Lam CY, Wetter DW. The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance. JMIR Form Res. 2023 Jun 20; 7:e39487. PMID: 37338956; PMCID: PMC10337448.
      Citations:    
    4. Correa-Fern?ndez V, Blalock JA, Piper ME, Canino G, Wetter DW. Acceptance and Commitment Therapy Wellness Program for Latine Adults Who Smoke and Have Psychological Distress: Protocol for a Feasibility Study. JMIR Res Protoc. 2023 Apr 04; 12:e44146. PMID: 37014678.
      Citations:    
    5. Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety. 2022 05; 39(5):429-440. PMID: 35535436; PMCID: PMC9705120.
      Citations:    Fields:    Translation:Humans
    6. Robinson JD, Karam-Hage M, Kypriotakis G, Beneventi D, Blalock JA, Cui Y, Gonzalez R, Tayar J, Chaftari P, Cinciripini PM. Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict. 2022 05; 31(3):236-241. PMID: 35347796; PMCID: PMC9117427.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    7. Salloum RG, Rojewski AM, Piper ME, Blalock JA, Borrelli B, Boyce LM, Minnix JA, Dogar O, Tomko RL, Jorenby DE, Kotsen C, Ostroff JS. Reporting Treatment Fidelity in Behavioral Tobacco Treatment Clinical Trials: Scoping Review and Measurement Recommendations. Nicotine Tob Res. 2022 02 01; 24(2):150-159. PMID: 34197617; PMCID: PMC9013002.
      Citations:    Fields:    Translation:HumansAnimals
    8. Rodriguez-Cano R, Paulus DJ, Derrick JL, Blalock JA, Zvolensky MJ. Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers. J Subst Abuse Treat. 2022 01; 132:108508. PMID: 34098209; PMCID: PMC8630077.
      Citations:    Fields:    Translation:Humans
    9. Sharma A, Chen M, Blalock J, Ortiz J, Weaver L, Shete S, Tam?-Maury I. Comparing smoking behavior between female-to-male and male-to-female transgender adults. Tob Prev Cessat. 2020; 6:2. PMID: 32548339; PMCID: PMC7291890.
      Citations: 1     
    10. Cox-Martin E, Cox MG, Basen-Engquist K, Bradley C, Blalock JA. Changing multiple health behaviors in cancer survivors: smoking and exercise. Psychol Health Med. 2020 03; 25(3):331-343. PMID: 31630537; PMCID: PMC7033014.
      Citations: 1     Fields:    Translation:Humans
    11. Cinciripini PM, Karam-Hage M, Kypriotakis G, Robinson JD, Rabius V, Beneventi D, Minnix JA, Blalock JA. Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer. JAMA Netw Open. 2019 09 04; 2(9):e1912251. PMID: 31560387; PMCID: PMC6777393.
      Citations: 26     Fields:    Translation:Humans
    12. Minnix JA, Karam-Hage M, Blalock JA, Cinciripini PM. The importance of incorporating smoking cessation into lung cancer screening. Transl Lung Cancer Res. 2018 Jun; 7(3):272-280. PMID: 30050765; PMCID: PMC6037969.
      Citations: 13     
    13. Cofta-Woerpel L, Lam C, Reitzel LR, Wilson W, Karam-Hage M, Beneventi D, Cofer J, Baker E, Wetter DW, Cinciripini PM, Blalock J. A tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers. Cogent Med. 2018; 5(1). PMID: 30364535; PMCID: PMC6197484.
      Citations: 2     
    14. Karam-Hage M, Kypriotakis G, Robinson JD, Green CE, Mann G, Rabius V, Wippold R, Blalock JA, Mouhayar E, Tayar J, Chaftari P, Cinciripini PM. Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. J Clin Psychopharmacol. 2018 Feb; 38(1):34-41. PMID: 29232312; PMCID: PMC5997410.
      Citations:    Fields:    Translation:Humans
    15. Cox M, Basen-Engquist K, Carmack CL, Blalock J, Li Y, Murray J, Pisters L, Rodriguez-Bigas M, Song J, Cox-Martin E, Demark-Wahnefried W. Comparison of Internet and Telephone Interventions for Weight Loss Among Cancer Survivors: Randomized Controlled Trial and Feasibility Study. JMIR Cancer. 2017 Sep 27; 3(2):e16. PMID: 28954716; PMCID: PMC5637068.
      Citations: 11     
    16. Karam-Hage M, Oughli HA, Rabius V, Beneventi D, Wippold RC, Blalock JA, Cinciripini PM. Tobacco Cessation Treatment Pathways for Patients With Cancer: 10 Years in the Making. J Natl Compr Canc Netw. 2016 11; 14(11):1469-1477. PMID: 27799514; PMCID: PMC5909831.
      Citations: 18     Fields:    Translation:Humans
    17. Farris SG, Robinson JD, Zvolensky MJ, Hogan J, Rabius V, Cinciripini PM, Karam-Hage M, Blalock JA. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addict Behav. 2016 10; 61:32-9. PMID: 27235990; PMCID: PMC5912332.
      Citations: 4     Fields:    Translation:Humans
    18. Martin EC, Basen-Engquist K, Cox MG, Lyons EJ, Carmack CL, Blalock JA, Demark-Wahnefried W. Interest in Health Behavior Intervention Delivery Modalities Among Cancer Survivors: A Cross-Sectional Study. JMIR Cancer. 2016 Feb 11; 2(1):e1. PMID: 28410164; PMCID: PMC5369635.
      Citations: 20     
    19. Bluethmann SM, Basen-Engquist K, Vernon SW, Cox M, Gabriel KP, Stansberry SA, Carmack CL, Blalock JA, Demark-Wahnefried W. Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors. Psychooncology. 2015 Oct; 24(10):1250-1257. PMID: 26060053; PMCID: PMC4698101.
      Citations: 39     Fields:    
    20. Wippold R, Karam-Hage M, Blalock J, Cinciripini P. Selection of optimal tobacco cessation medication treatment in patients with cancer. Clin J Oncol Nurs. 2015 Apr; 19(2):170-5. PMID: 25840382; PMCID: PMC6029249.
      Citations: 3     Fields:    Translation:Humans
    21. Parrott CE, Rathnayaka N, Blalock JA, Minnix JA, Cinciripini PM, Vincent JP, Wetter DW, Green C. Examination of the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Factor Structure in a Sample of Pregnant Smokers. Nicotine Tob Res. 2015 Jun; 17(6):653-60. PMID: 25475086; PMCID: PMC4838051.
      Citations:    Fields:    Translation:Humans
    22. Lin J, Blalock JA, Chen M, Ye Y, Gu J, Cohen L, Cinciripini PM, Wu X. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):336-43. PMID: 25416716; PMCID: PMC4332382.
      Citations: 13     Fields:    Translation:HumansCells
    23. Stotts AL, Northrup TF, Cinciripini PM, Minnix JA, Blalock JA, Mullen PD, Pedroza C, Blackwell S. Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions. Am J Perinatol. 2015 Mar; 32(4):351-6. PMID: 25111040; PMCID: PMC5937922.
      Citations: 7     Fields:    Translation:Humans
    24. Farris SG, Zvolensky MJ, Blalock JA, Schmidt NB. Negative affect and smoking motives sequentially mediate the effect of panic attacks on tobacco-relevant processes. Am J Drug Alcohol Abuse. 2014 May; 40(3):230-9. PMID: 24720260; PMCID: PMC5908468.
      Citations: 13     Fields:    Translation:Humans
    25. Almirall D, Blalock JA. Summary of the SRNT treatment network Webinar: getting SMART about developing individualized sequences of health interventions. Nicotine Tob Res. 2014 Feb; 16(2):252. PMID: 24302636; PMCID: PMC8444779.
      Citations: 1     Fields:    Translation:Humans
    26. Rabius V, Karam-Hage M, Blalock JA, Cinciripini PM. "Meaningful use" provides a meaningful opportunity. Cancer. 2014 Feb 15; 120(4):464-8. PMID: 24496865; PMCID: PMC4054930.
      Citations: 7     Fields:    Translation:Humans
    27. Blalock JA, Minnix JA, Mathew AR, Wetter DW, McCullough JP, Cinciripini PM. Relationship of childhood trauma to depression and smoking outcomes in pregnant smokers. J Consult Clin Psychol. 2013 Oct; 81(5):821-30. PMID: 23750463; PMCID: PMC3905676.
      Citations: 8     Fields:    Translation:Humans
    28. Mathew AR, Robinson JD, Norton PJ, Cinciripini PM, Brown RA, Blalock JA. Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine Tob Res. 2013 Nov; 15(11):1807-15. PMID: 23509093; PMCID: PMC3790623.
      Citations: 13     Fields:    Translation:Humans
    29. Blalock JA, Nayak N, Wetter DW, Schreindorfer L, Minnix JA, Canul J, Cinciripini PM. The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychol Addict Behav. 2011 Dec; 25(4):652-63. PMID: 21928869; PMCID: PMC4093831.
      Citations: 11     Fields:    Translation:Humans
    30. Minnix JA, Blalock JA, Marani S, Prokhorov AV, Cinciripini PM. Self-efficacy mediates the effect of depression on smoking susceptibility in adolescents. Nicotine Tob Res. 2011 Aug; 13(8):699-705. PMID: 21482619; PMCID: PMC3150689.
      Citations: 10     Fields:    Translation:Humans
    31. Blalock JA, Lam C, Minnix JA, Karam-Hage M, Gritz ER, Robinson JD, Cinciripini PM. The Effect of Mood, Anxiety, and Alcohol Use Disorders on Smoking Cessation in Cancer Patients. J Cogn Psychother. 2011; 25(1):82-96. PMID: 35115739; PMCID: PMC8809502.
      Citations:    Fields:    
    32. Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, Wetter DW, Schreindorfer L, McCullough JP, Dolan-Mullen P, Stotts AL, Karam-Hage M. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. J Consult Clin Psychol. 2010 Feb; 78(1):44-54. PMID: 20099949; PMCID: PMC2881321.
      Citations: 32     Fields:    Translation:Humans
    33. Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behav Genet. 2010 Jan; 40(1):49-58. PMID: 19842028; PMCID: PMC3719969.
      Citations: 3     Fields:    Translation:Humans
    34. Maddux RE, Riso LP, Klein DN, Markowitz JC, Rothbaum BO, Arnow BA, Manber R, Blalock JA, Keitner GI, Thase ME. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord. 2009 Oct; 117(3):174-9. PMID: 19217168.
      Citations: 11     Fields:    Translation:Humans
    35. Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychol Addict Behav. 2008 Mar; 22(1):122-8. PMID: 18298238.
      Citations: 20     Fields:    Translation:Humans
    36. Blalock JA, Robinson JD, Wetter DW, Cinciripini PM. Relationship of DSM-IV-based depressive disorders to smoking cessation and smoking reduction in pregnant smokers. Am J Addict. 2006 Jul-Aug; 15(4):268-77. PMID: 16867921.
      Citations: 21     Fields:    Translation:Humans
    37. Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry. 2005 May; 62(5):513-20. PMID: 15867104.
      Citations: 27     Fields:    Translation:HumansCTClinical Trials
    38. Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addict Behav. 2005 Jul; 30(6):1195-208. PMID: 15925128.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    39. Klein DN, Santiago NJ, Vivian D, Blalock JA, Kocsis JH, Markowitz JC, McCullough JP, Rush AJ, Trivedi MH, Arnow BA, Dunner DL, Manber R, Rothbaum B, Thase ME, Keitner GI, Miller IW, Keller MB. Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. J Consult Clin Psychol. 2004 08; 72(4):681-8. PMID: 15301653.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    40. Klein DN, Schwartz JE, Santiago NJ, Vivian D, Vocisano C, Castonguay LG, Arnow B, Blalock JA, Manber R, Markowitz JC, Riso LP, Rothbaum B, McCullough JP, Thase ME, Borian FE, Miller IW, Keller MB. Therapeutic alliance in depression treatment: controlling for prior change and patient characteristics. J Consult Clin Psychol. 2003 Dec; 71(6):997-1006. PMID: 14622075.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    41. Arnow BA, Manber R, Blasey C, Klein DN, Blalock JA, Markowitz JC, Rothbaum BO, Rush AJ, Thase ME, Riso LP, Vivian D, McCullough JP, Keller MB. Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. J Consult Clin Psychol. 2003 Dec; 71(6):1025-35. PMID: 14622078.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    42. Cinciripini PM, Wetter DW, Fouladi RT, Blalock JA, Carter BL, Cinciripini LG, Baile WF. The effects of depressed mood on smoking cessation: mediation by postcessation self-efficacy. J Consult Clin Psychol. 2003 Apr; 71(2):292-301. PMID: 12699023.
      Citations: 82     Fields:    Translation:HumansCTClinical Trials
    43. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000 May 18; 342(20):1462-70. PMID: 10816183.
      Citations: 221     Fields:    Translation:HumansCTClinical Trials
    44. Miller SM, Blalock J, Ginsburg HJ. Children and the aged: attitudes, contact, and discriminative ability. Int J Aging Hum Dev. 1984-1985; 19(1):47-53. PMID: 6519815.
      Citations: 2     Fields:    Translation:Humans
    45. Gender differences in depression. Sex Roles. 33:91-108.
    46. Selection of optimal tobacco cessation medication treatment in patients with cancer. Clinical Journal of Oncology Nursing. 19:170-176.
    47. Interaction of cognitive avoidance coping and stress in predicting depression/anxiety. Cognitive Therapy and Research. 24:47-65.
    48. The effect of mood, anxiety, and alcohol use disorders on smoking cessation in cancer patients. Journal of Cognitive Psychotherapy. 25:82-96.
    49. When will bulimics be depressed and when not? The moderating role of attributional style. Cognitive Therapy and Research. 21:61-72.
    50. Therapist variables that predict symptom change in psychotherapy with chronically depressed outpatients. Psychotherapy. 41:255-265.
    51. Cognitive and behavioral mediators of combined pharmacotherapy and psychotherapy of chronic depression. Cognitive Therapy and Research. 32:197-211.
    52. The therapeutic alliance and CBASP-specific skill acquisition in the treatment of chronic depression. Cognitive Therapy and Research. 29:803-817.
    53. Tobacco cessation treatment pathways for patients with cancer. JNCCN Journal of the National Comprehensive Cancer Network. 14:1469-1477.
    54. Masculine gender role stress. Clinical Psychology Review. 11:45-60.
    55. Grasping the 'teachable moment'. Psycho-Oncology. 24:1250-1257.
    56. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addictive Behaviors. 61:32-39.
    BLALOCK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (139)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _